Skip to main content
. 2011 Oct 25;6(10):e25364. doi: 10.1371/journal.pone.0025364

Figure 3. Enrichment of drug targets in consensus and original signatures (hypergeometric test).

Figure 3

The black line indicates a 5% significance threshold. The full list of all drug targets and therapeutic compounds is available in Table S4.